GSK Equity Investments No2 Limited

Active08603529 Private limited company
Incorporated
10 July 2013 (13 years)
Previously known as
Action Potential Venture Capital Limited (until 25 September 2026)
Industry
Research and experimental development on biotechnology (72110)
Directors
Owned by
Accounts type
Small
Region
East of England
Address
Gsk Medicines Research Centre
Gunnels Wood Road
Stevenage
SG1 2NY

Website & contact details

Group website
The site of this company’s group or brand.

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
1 October 2027
Last conf. stmt
17 September 2026

Officers 5 active

Officer details are public data from the Companies House register.

Director · Appointed 26 April 2019
Also at Galvani Bioelectronics Limited · more companies
British
Born May 1962 (64)
Director · Appointed 3 June 2015
Also at Glaxosmithkline Intellectual Property Holdings Limited, Glaxosmithkline Intellectual Property Limited, Smithkline Beecham Legacy H Limited · more companies
British
Born November 1967
Corporate Secretary · Appointed 10 July 2013
Also at British Pharma Group Limited, Glaxosmithkline Services Unlimited, Beecham Group PLC · more companies
Corporate Director · Appointed 10 July 2013
Also at Glaxosmithkline Services Unlimited, Beecham Group PLC, Dealcyber Limited · more companies
Corporate Director · Appointed 10 July 2013
Also at Glaxo Group Limited, Glaxosmithkline Finance PLC, Glaxosmithkline Intellectual Property Management Limited · more companies
Officer history (4 former)
31 December 2025
Resigned Lynch, Ciara Martha as Director
2 March 2020
Resigned Panagiotidis, Charalampos as Director
2 March 2020
Appointed Lynch, Ciara Martha as Director
31 May 2019
Resigned Eckstein, Jens, Dr as Director
26 April 2019
Appointed Williams, Subesh Ronald as Director
15 February 2019
Appointed Panagiotidis, Charalampos as Director
1 March 2016
Resigned Blackburn, Paul Frederick as Director
3 June 2015
Appointed Walker, Adam as Director
10 September 2013
Appointed Eckstein, Jens, Dr as Director
10 July 2013
Appointed The Wellcome Foundation Limited as Corporate Director
10 July 2013
Appointed Glaxo Group Limited as Corporate Director
10 July 2013
Appointed Blackburn, Paul Frederick as Director
10 July 2013
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 305979

Filings 53

DateDescriptionMade Up ToPagesPDF
19 October 2026Memorandum and Articles of Association
25 September 2026Certificate of change of name
17 September 2026Confirmation statement with no updates17 September 2026
27 June 2026Accounts for a small company31 December 2025
6 January 2026Termination of appointment of a director
Show all 53 filings

Some other companies at this address

Domantis Limited
Galvani Bioelectronics Limited
Glaxo Group Limited
Glaxo Wellcome UK Limited
Glaxosmithkline Intellectual Property (No.2) Limited
Glaxosmithkline Intellectual Property (No.3) Limited

Other companies in this industry

Oxford
Sandwich
Newcastle Upon Tyne
London
London
Edinburgh

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?